Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis.

Zhang C, Sun A, Zhang P, Wu C, Zhang S, Fu M, Wang K, Zou Y, Ge J.

Diabetes Res Clin Pract. 2010 Feb;87(2):211-8. doi: 10.1016/j.diabres.2009.09.029. Epub 2009 Oct 23.

PMID:
19853947
2.
3.

Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis.

Berger JS, Brown DL, Becker RC.

Am J Med. 2008 Jan;121(1):43-9. doi: 10.1016/j.amjmed.2007.10.002. Review.

PMID:
18187072
4.

Update on aspirin in the treatment and prevention of cardiovascular disease.

Hennekens CH.

Am J Manag Care. 2002 Dec;8(22 Suppl):S691-700. Review.

5.

Adenosine-diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus.

Valentine N, Van de Laar FA, van Driel ML.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD005449. doi: 10.1002/14651858.CD005449.pub2. Review.

PMID:
23152231
6.

Meta-analysis of the efficacy and safety of clopidogrel plus aspirin as compared to antiplatelet monotherapy for the prevention of vascular events.

Bowry AD, Brookhart MA, Choudhry NK.

Am J Cardiol. 2008 Apr 1;101(7):960-6. doi: 10.1016/j.amjcard.2007.11.057. Epub 2008 Feb 11. Review.

PMID:
18359315
7.

Antiplatelet agents for the prevention of cardiovascular disease in diabetes mellitus.

Colwell JA.

Am J Cardiovasc Drugs. 2004;4(2):87-106. Review.

PMID:
15049721
8.

Aspirin therapy and primary prevention of cardiovascular disease in diabetes mellitus.

Younis N, Williams S, Soran H.

Diabetes Obes Metab. 2009 Nov;11(11):997-1000. doi: 10.1111/j.1463-1326.2009.01068.x. Epub 2009 Jun 16. Review.

PMID:
19531055
9.

[Primary prevention of cardiovascular diseases with acetylsalicylic acid].

Waltering A, Hemkens L, Florack C.

Dtsch Med Wochenschr. 2005 Dec 9;130(49):2847-52. Review. German.

PMID:
16317615
10.

Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: a systematic review and meta-analysis.

Butalia S, Leung AA, Ghali WA, Rabi DM.

Cardiovasc Diabetol. 2011 Apr 1;10:25. doi: 10.1186/1475-2840-10-25. Review.

11.

Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials.

De Berardis G, Sacco M, Strippoli GF, Pellegrini F, Graziano G, Tognoni G, Nicolucci A.

BMJ. 2009 Nov 6;339:b4531. doi: 10.1136/bmj.b4531. Review. Erratum in: BMJ. 2010;340:c374.

12.

The platelet in diabetes: focus on prevention of ischemic events.

Colwell JA, Nesto RW.

Diabetes Care. 2003 Jul;26(7):2181-8. Review.

PMID:
12832332
13.

Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.

Jones L, Griffin S, Palmer S, Main C, Orton V, Sculpher M, Sudlow C, Henderson R, Hawkins N, Riemsma R.

Health Technol Assess. 2004 Oct;8(38):iii-iv, 1-196. Review.

14.

Aspirin and primary cardiovascular prevention. Uncertain balance between benefits and risks.

[No authors listed]

Prescrire Int. 2010 Nov;19(110):258-61. Review.

PMID:
21284360
15.

Effect of aspirin dose on mortality and cardiovascular events in people with diabetes: a meta-analysis.

Simpson SH, Gamble JM, Mereu L, Chambers T.

J Gen Intern Med. 2011 Nov;26(11):1336-44. doi: 10.1007/s11606-011-1757-y. Epub 2011 Jun 7. Review.

16.

The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.

Hennekens CH, Schneider WR.

Expert Rev Cardiovasc Ther. 2008 Jan;6(1):95-107. Review.

PMID:
18095910
17.
18.
20.

Aspirin for primary prevention of cardiovascular events in people with diabetes.

Pignone M, Alberts MJ, Colwell JA, Cushman M, Inzucchi SE, Mukherjee D, Rosenson RS, Williams CD, Wilson PW, Kirkman MS; American Diabetes Association; American Heart Association; American College of Cardiology Foundation.

J Am Coll Cardiol. 2010 Jun 22;55(25):2878-86. doi: 10.1016/j.jacc.2010.04.003. Review. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk